210 related articles for article (PubMed ID: 16101549)
1. Pro and antiinflammatory properties of toxins from animal venoms.
Farsky SH; Antunes E; Mello SB
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):401-11. PubMed ID: 16101549
[TBL] [Abstract][Full Text] [Related]
2. Venoms and Isolated Toxins from Snakes of Medical Impact in the Northeast Argentina: State of the Art. Potential Pharmacological Applications.
Garcia Denegri ME; Bustillo S; Gay CC; Van De Velde A; Gomez G; Echeverría S; Gauna Pereira MDC; Maruñak S; Nuñez S; Bogado F; Sanchez M; Teibler GP; Fusco L; Leiva LCA
Curr Top Med Chem; 2019; 19(22):1962-1980. PubMed ID: 31345151
[TBL] [Abstract][Full Text] [Related]
3. [Facts on venomous animals].
Goyffon M
Ann Pharm Fr; 1994; 52(2):99-109. PubMed ID: 7944185
[TBL] [Abstract][Full Text] [Related]
4. South American snake venoms with abundant neurotoxic components. Composition and toxicological properties. A literature review.
Baudou FG; Rodriguez JP; Fusco L; de Roodt AR; De Marzi MC; Leiva L
Acta Trop; 2021 Dec; 224():106119. PubMed ID: 34481791
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the understanding of brown spider venoms: From the biology of spiders to the molecular mechanisms of toxins.
Gremski LH; Trevisan-Silva D; Ferrer VP; Matsubara FH; Meissner GO; Wille AC; Vuitika L; Dias-Lopes C; Ullah A; de Moraes FR; Chávez-Olórtegui C; Barbaro KC; Murakami MT; Arni RK; Senff-Ribeiro A; Chaim OM; Veiga SS
Toxicon; 2014 Jun; 83():91-120. PubMed ID: 24631373
[TBL] [Abstract][Full Text] [Related]
6. Determination of sphingomyelinase-D activity of Loxosceles venoms in sphingomyelin/cholesterol liposomes containing horseradish peroxidase.
Gomes MT; Guimarães G; Frézard F; Kalapothakis E; Minozzo JC; Chaim OM; Veiga SS; Oliveira SC; Chávez-Olórtegui C
Toxicon; 2011 Mar; 57(4):574-9. PubMed ID: 21236288
[TBL] [Abstract][Full Text] [Related]
7. New insights on arthropod toxins that potentiate erectile function.
Nunes KP; Torres FS; Borges MH; Matavel A; Pimenta AM; De Lima ME
Toxicon; 2013 Jul; 69():152-9. PubMed ID: 23583324
[TBL] [Abstract][Full Text] [Related]
8. Antidotes against venomous animals: state of the art and prospectives.
Espino-Solis GP; Riaño-Umbarila L; Becerril B; Possani LD
J Proteomics; 2009 Mar; 72(2):183-99. PubMed ID: 19457345
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of local effects caused by Bothrops alternatus and Bothrops moojeni snake venoms: enzymatic contributions and inflammatory modulations.
Mamede CC; de Sousa BB; Pereira DF; Matias MS; de Queiroz MR; de Morais NC; Vieira SA; Stanziola L; de Oliveira F
Toxicon; 2016 Jul; 117():37-45. PubMed ID: 26975252
[TBL] [Abstract][Full Text] [Related]
10. Sphero-echinocytosis of human red blood cells caused by snake, red-back spider, bee and blue-ringed octopus venoms and its inhibition by snake sera.
Flachsenberger W; Leigh CM; Mirtschin PJ
Toxicon; 1995 Jun; 33(6):791-7. PubMed ID: 7676470
[TBL] [Abstract][Full Text] [Related]
11. Inflammation induced by Bothrops asper venom.
Teixeira C; Cury Y; Moreira V; Picolo G; Chaves F
Toxicon; 2009 Jul; 54(1):67-76. PubMed ID: 19328821
[TBL] [Abstract][Full Text] [Related]
12. Bites and stings from venomous animals: a global overview.
White J
Ther Drug Monit; 2000 Feb; 22(1):65-8. PubMed ID: 10688262
[TBL] [Abstract][Full Text] [Related]
13. Fluorometric assay using naphthylamide substrates for assessing novel venom peptidase activities.
Gasparello-Clemente E; Silveira PF
Toxicon; 2002 Nov; 40(11):1617-26. PubMed ID: 12419513
[TBL] [Abstract][Full Text] [Related]
14. Comparison of phospholipase activity with direct and indirect lytic effects of animal venoms upon human red cells.
Sosa BP; Alagón AC; Possani LD; Juliá JZ
Comp Biochem Physiol B; 1979; 64(2):231-4. PubMed ID: 318305
[TBL] [Abstract][Full Text] [Related]
15. Brown Spider (
Chaves-Moreira D; Matsubara FH; Schemczssen-Graeff Z; De Bona E; Heidemann VR; Guerra-Duarte C; Gremski LH; Chávez-Olórtegui C; Senff-Ribeiro A; Chaim OM; Arni RK; Veiga SS
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31248109
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
17. [Toxicity of venoms from snakes of medical importance in México].
de Roodt AR; Estévez-Ramírez J; Paniagua-Solís JF; Litwin S; Carvajal-Saucedo A; Dolab JA; Robles-Ortiz LE; Alagón A
Gac Med Mex; 2005; 141(1):13-21. PubMed ID: 15754746
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
Guilherme P; Fernandes I; Barbaro KC
Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone antagonizes the in vivo myotoxic and inflammatory effects of Bothrops venoms.
Patrão-Neto FC; Tomaz MA; Strauch MA; Monteiro-Machado M; Rocha JR; Borges PA; Calil-Elias S; Melo PA
Toxicon; 2013 Jul; 69():55-64. PubMed ID: 23416798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
